PAR-20-084 - NIBIB Trailblazer Award for New and Early Stage Investigators (R21 Clinical Trial Optional) is used for the submission of applications to the following Notices of Special Interest (NOSIs)
On This Page: 4
Active NOSIs
Title | Notice Number | Organization | Release Date |
Expiration Date |
Activity Code(s) |
---|
Expired NOSIs
Title | Notice Number | Organization | Release Date |
Expiration Date |
Activity Code(s) |
---|---|---|---|---|---|
Notice of Special Interest (NOSI): Technological Innovations for Advancing Clinical SPECT Imaging | NOT-EB-22-006 | NIBIB | Mar 21, 2022 | May 8, 2024 | R21, F30, K01, R13, K23, K25, R43/R44, K08, R01, K99/R00, R41/R42, F32, R03, F31 |
Notice of Participation of the National Institute on Aging (NIA) in PAR-20-084 "NIBIB Trailblazer Award for New and Early Stage Investigators (R21 Clinical Trial Optional)" | NOT-AG-22-019 | NIA | Mar 11, 2022 | n/a | R21 |
Notice of Special Interest (NOSI): Navigating Pediatric to Adult Health Care: Lost in Transition | NOT-HD-21-027 | NICHD NIAAA NCI NIMH NIAMS OBSSR NIBIB NIDCR | Jun 22, 2021 | Jan 8, 2024 | R01, R21, R43/R44, R41/R42 |
Notice of Special Interest (NOSI): Development of Biomedical Technologies for Coronavirus Disease 2019 (COVID-19) | NOT-EB-20-007 | NIBIB | Apr 10, 2020 | Aug 29, 2020 | R01, R21, R03 |